These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505 [TBL] [Abstract][Full Text] [Related]
9. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845 [TBL] [Abstract][Full Text] [Related]
10. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients. van Agthoven T; Eijkenboom WMH; Looijenga LHJ Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337 [TBL] [Abstract][Full Text] [Related]
11. Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels. Fankhauser CD; Wettstein MS; Christiansen AJ; Rothermundt C; Cathomas R; Kaufmann E; Sigg S; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Beyer J; Hermanns T Urol Oncol; 2024 Dec; 42(12):455.e9-455.e13. PubMed ID: 39261117 [TBL] [Abstract][Full Text] [Related]
12. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p? Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887 [TBL] [Abstract][Full Text] [Related]
13. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population. Kılınç MT; Göger YE; Özkent MS; Kılıç Ö; Okur Altındaş B; Yıldırım MS; Karalezli G Urol J; 2024 Jun; 21(4):242-249. PubMed ID: 38629199 [TBL] [Abstract][Full Text] [Related]
14. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. Fankhauser CD; Christiansen AJ; Rothermundt C; Cathomas R; Wettstein MS; Grossmann NC; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T Br J Cancer; 2022 May; 126(8):1140-1144. PubMed ID: 34912073 [TBL] [Abstract][Full Text] [Related]
15. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor. Leão R; van Agthoven T; Figueiredo A; Jewett MAS; Fadaak K; Sweet J; Ahmad AE; Anson-Cartwright L; Chung P; Hansen A; Warde P; Castelo-Branco P; O'Malley M; Bedard PL; Looijenga LHJ; Hamilton RJ J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847 [TBL] [Abstract][Full Text] [Related]
16. The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens. Kremer L; von Brandenstein M; Wittersheim M; Koeditz B; Paffenholz P; Hellmich M; Pfister D; Heidenreich A; Nestler T Transl Androl Urol; 2021 Apr; 10(4):1647-1655. PubMed ID: 33968653 [TBL] [Abstract][Full Text] [Related]
17. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer. Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479 [TBL] [Abstract][Full Text] [Related]
18. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). van Agthoven T; Looijenga LHJ Oncotarget; 2017 Aug; 8(35):58037-58049. PubMed ID: 28938535 [TBL] [Abstract][Full Text] [Related]
19. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor. Belge G; Hennig F; Dumlupinar C; Grobelny F; Junker K; Radtke A; Dieckmann KP Oncotarget; 2020 Apr; 11(16):1462-1473. PubMed ID: 32363003 [No Abstract] [Full Text] [Related]
20. Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses. Matulewicz RS; Baky F; Knezevic A; Sheinfeld J; Williams BM; Kantor RE; Liso N; Hossain J; Bromberg M; Valentino A; So R; Funt SA; Ye F; Feldman DR Eur Urol Open Sci; 2024 Oct; 68():1-9. PubMed ID: 39257620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]